Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

l. molteni & c. dei f.lli alitti societa di esercizio s.p.a. - morphinsulfat - oral opløsning, enkeltdosisbeholder - 10 mg

Europeiska unionen - danska - EMA (European Medicines Agency)

l. molteni & c. dei fratelli alitti società di esercizio s.p.a. - buprenorphin hydrochlorid - opioid-relaterede lidelser - andre narkotika stoffer - sixmo er angivet til substitutionsbehandling for opioidafhængighed i klinisk stabile voksne patienter, der kræver mere end 8 mg/dag af sublingual buprenorphin, inden for en ramme af medicinsk, social og psykologisk behandling.

Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

noucor health s.a. - rupatadinfumarat - oral opløsning - 1 mg/ml

Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

noucor health s.a. - rupatadinfumarat - tabletter - 10 mg

Europeiska unionen - danska - EMA (European Medicines Agency)

vetoquinol - triptorelin acetate - hypofysiske og hypotalamiske hormoner og analoger - pigs (sows for reproduction) - for the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.

Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

krka d.d. novo mesto - nebivololhydrochlorid - tabletter - 5 mg

Europeiska unionen - danska - EMA (European Medicines Agency)

pharmathen s.a. - irbesartan - forhøjet blodtryk - agenter, der virker på renin-angiotensinsystemet - sabervel er indiceret hos voksne til behandling af essentiel hypertension. det er også indiceret til behandling af nyresygdom hos voksne patienter med hypertension og type 2-diabetes mellitus som en del af et blodtrykssænkende lægemiddel regime.

Danmark - danska - SEGES Landbrug & Fødevarer

forhandles af flere firmaer. - bor - granulat - 210 g/kg bor

Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - eng-rottehale - frysetørret tablet - 75.000 sq.t

Europeiska unionen - danska - EMA (European Medicines Agency)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - immunosuppressiva - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) er indiceret til behandling af voksne patienter med tidligere ubehandlet myelomatose, der ikke er berettiget til transplantation. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) er indiceret til behandling af voksne patienter med tidligere ubehandlet myelomatose, der ikke er berettiget til transplantation. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).